Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.674E-13 | 5.823E-09 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.330E-11 | 3.625E-07 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 9.562E-11 | 6.940E-07 | CA1, CA12, CA13, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.627E-13 | 1.481E-11 | CA12; CA1; CA7; CA9; CA13 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.828E-04 | 2.924E-03 | CYP1A2; CYP2C19 |
hsa05134 | Legionellosis_Homo sapiens_hsa05134 | 6.615E-04 | 6.541E-03 | CASP7; CASP1 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 9.229E-04 | 6.541E-03 | CYP1A2; ALDH1A1 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.039E-03 | 6.541E-03 | CYP1A2; CYP2C19 |
hsa05133 | Pertussis_Homo sapiens_hsa05133 | 1.226E-03 | 6.541E-03 | CASP7; CASP1 |
hsa05204 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.464E-03 | 6.691E-03 | CYP1A2; CYP2C19 |
hsa04210 | Apoptosis_Homo sapiens_hsa04210 | 4.190E-03 | 1.490E-02 | CASP7; LMNA |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 8.888E-03 | 2.585E-02 | CYP1A2; ALDH1A1; CYP2C19; HSD17B10 |
hsa05010 | Alzheimer's disease_Homo sapiens_hsa05010 | 5.973E-03 | 1.911E-02 | CASP7; HSD17B10 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.495E-03 | 1.398E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | CA1 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9 |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CASP1 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9 |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | CA1; CA1 |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | CASP1 |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA1 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
L00-L99: Diseases of the skin and subcutaneous tissue | Fibrosis | L90.5 | CASP1 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |